This study aims to evaluate the corrosion behavior of WE43 alloy with plasma electrolytic oxidation (PEO)/hydroxyapatite (HA)-polydopamine (PDA) duplex coating. HA-PDA is co-deposited as the top layer using an electrodeposition process by varied dopamine hydrochloride concentration and deposition time following the PEO process. The findings show the development of a corrosion-resistant coating by regulating the surface morphology. Furthermore, long-term electrochemical impedance spectroscopy reveals that the total impedance of the optimized PEO/HA-PDA coating (deposition time = 10 min and dopamine hydrochloride concentration = 1 mg/mL) increased from 1720 Ω on day 1 to 14,600 Ω following 21 days of immersion. Co-deposited HA-PDA shows less hydrogen release and higher adhesion strength than PEO/HA samples. Finally, the PEO/HA-PDA coating is desirable for magnesium bone implants by considering the bioactivity of the coating resulting in improved cell-surface interaction.
Farshid S., Kharaziha M., Atapour M., Di Franco F., Santamaria M. (2024). Duplex plasma electrolytic oxidation/ hydroxyapatite- polydopamine coating on WE43 alloy for bone implants: Long-term corrosion resistance and biological properties. SURFACE & COATINGS TECHNOLOGY, 493(part 2) [10.1016/j.surfcoat.2024.131262].
Duplex plasma electrolytic oxidation/ hydroxyapatite- polydopamine coating on WE43 alloy for bone implants: Long-term corrosion resistance and biological properties
Di Franco F.;Santamaria M.
2024-10-15
Abstract
This study aims to evaluate the corrosion behavior of WE43 alloy with plasma electrolytic oxidation (PEO)/hydroxyapatite (HA)-polydopamine (PDA) duplex coating. HA-PDA is co-deposited as the top layer using an electrodeposition process by varied dopamine hydrochloride concentration and deposition time following the PEO process. The findings show the development of a corrosion-resistant coating by regulating the surface morphology. Furthermore, long-term electrochemical impedance spectroscopy reveals that the total impedance of the optimized PEO/HA-PDA coating (deposition time = 10 min and dopamine hydrochloride concentration = 1 mg/mL) increased from 1720 Ω on day 1 to 14,600 Ω following 21 days of immersion. Co-deposited HA-PDA shows less hydrogen release and higher adhesion strength than PEO/HA samples. Finally, the PEO/HA-PDA coating is desirable for magnesium bone implants by considering the bioactivity of the coating resulting in improved cell-surface interaction.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0257897224008934-main.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
8.78 MB
Formato
Adobe PDF
|
8.78 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
